Ravoxertinib

Ravoxertinib Uses, Dosage, Side Effects, Food Interaction and all others data.

Ravoxertinib is under investigation in clinical trial NCT01875705 (A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors).

Trade Name Ravoxertinib
Generic Ravoxertinib
Ravoxertinib Other Names Ravoxertinib
Type
Formula C21H18ClFN6O2
Weight Average: 440.86
Monoisotopic: 440.1163797
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Ravoxertinib
Ravoxertinib

Innovators Monograph

You find simplified version here Ravoxertinib

*** Taking medicines without doctor's advice can cause long-term problems.
Share